These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32437951)

  • 21. Midterm results of endovascular treatment of superficial femoral artery disease with biodegradable stents: single-center experience.
    Silingardi R; Lauricella A; Coppi G; Nicolosi E; Gennai S; Coppi G
    J Vasc Interv Radiol; 2015 Mar; 26(3):374-81.e1. PubMed ID: 25636670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of routine surveillance duplex ultrasound and subsequent reintervention after superficial femoral artery stenting.
    Shih M; Pizano A; Solano A; Porras-Colon J; Babb J; Timaran CH; Baig MS; Siah M; Gonzalez-Guardiola G; Kirkwood ML
    J Vasc Surg; 2024 Jan; 79(1):102-110. PubMed ID: 37704092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous Viabahn-assisted subintimal recanalization for severe superficial femoral artery occlusive disease.
    Verta MJ; Schneider JR; Alonzo MJ; Hahn D
    J Vasc Interv Radiol; 2008 Apr; 19(4):493-8. PubMed ID: 18375291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
    Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
    J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of stents with bioactive coating in treatment of patients with lesions of the superficial femoral artery].
    Generalov MI; Maĭstrenko DN; Oleshchuk AN; Ivanov AS; Granov DA; Ovchinnikov IV; Khmel'nitskiĭ AV; Gusinskiĭ AV
    Angiol Sosud Khir; 2016; 22(3):59-64. PubMed ID: 27626251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
    de Grijs D; Teixeira P; Katz S
    J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
    Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease.
    Taeymans K; Groot Jebbink E; Holewijn S; Martens JM; Versluis M; Goverde PCJM; Reijnen MMPJ
    J Vasc Surg; 2018 May; 67(5):1438-1447. PubMed ID: 29169878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty.
    Lin TC; Huang CY; Chen PL; Lee CY; Shih CC; Chen IM
    J Endovasc Ther; 2018 Jun; 25(3):313-319. PubMed ID: 29673299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of isolated femoropopliteal in-stent restenosis.
    Qato K; Conway AM; Mondry L; Giangola G; Carroccio A
    J Vasc Surg; 2018 Sep; 68(3):807-810. PubMed ID: 30144908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective multicentre analysis of S.M.A.R.T. vs. Luminexx nitinol stent implantation for superficial femoral artery lesions (REAL SL) Registry. 5 years' experience.
    Iida O; Soga Y; Hirano K; Okamoto S; Dohi T; Uematsu M; Yokoi H; Nobuyoshi M; Muramatsu T; Fujita M; Nanto S; Nagata S
    Circ J; 2011; 75(2):421-7. PubMed ID: 21224520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous angioplasty and stenting of the superficial femoral artery.
    Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
    J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated femoral endarterectomy: impact of SFA TASC classification on recurrence of symptoms and need for additional intervention.
    Al-Khoury G; Marone L; Chaer R; Rhee R; Cho J; Leers S; Makaroun M; Gupta N
    J Vasc Surg; 2009 Oct; 50(4):784-9. PubMed ID: 19628359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of the ipsilateral superficial femoral artery on iliac angioplasty.
    Kudo T; Rigberg DA; Reil TD; Chandra FA; Ahn SS
    Ann Vasc Surg; 2006 Jul; 20(4):502-11. PubMed ID: 16732446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Below-knee bare nitinol stent placement in high-risk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice.
    Donas KP; Schwindt A; Schönefeld T; Tessarek J; Torsello G
    Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):688-93. PubMed ID: 19328021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.